Guillain-Barré Syndrome Associated with COVID-19 Vaccination
Guillain-Barré Syndrome Associated with COVID-19 Vaccination
About this item
Full title
Author / Creator
Publisher
Atlanta: U.S. National Center for Infectious Diseases
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: U.S. National Center for Infectious Diseases
Subjects
More information
Scope and Contents
Contents
We conducted a multi-institutional study in Taiwan and a systematic review of the literature for reports of Guillain-Barré syndrome after coronavirus disease vaccination. This condition, mostly the classic form and the acute inflammatory demyelinating polyneuropathy subtype, has been reported in 39 cases and has occurred within 2 weeks of vaccine...
Alternative Titles
Full title
Guillain-Barré Syndrome Associated with COVID-19 Vaccination
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c7e3ab40479a461188b0269ac3a21c3c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c7e3ab40479a461188b0269ac3a21c3c
Other Identifiers
ISSN
1080-6040
E-ISSN
1080-6059
DOI
10.3201/eid2712.211634
